• uni logo

QS Rank:

verified

601

uni logo

Manchester Metropolitan University

flag

Manchester

United Kingdom

Overview

Cardiovascular disease remains the leading cause of death worldwide, highlighting the urgent need for rapid, cost-effective, and accurate diagnostic tools. Current methods for detecting cardiac biomarkers such as troponins, BNP, and CRP are often slow, expensive, and reliant on centralised laboratory facilities. This project aims to revolutionise point-of-care diagnostics by developing next-generation screen-printed electrochemical biosensor arrays capable of detecting multiple biomarkers simultaneously./nThe successful candidate will explore innovative electrode designs, advanced surface functionalisation strategies, and cutting-edge characterisation techniques (including Manchester Met’s unique in-situ electrochemical-AFM-nanoRaman (TERS) system) to optimise sensor performance. The research will progress from fundamental surface science to the fabrication of intelligent, multiplexed sensor arrays, enabling fast and reliable cardiovascular health monitoring./nThis exciting 3-year PhD will be conducted in collaboration with Cambridge Medical Technologies, ensuring strong translational impact and real-world relevance. The candidate will join Manchester Metropolitan University’s world-class Electrochemistry Research Group.
intake

Duration

3 Months

Ranking

icon

#877

US World and News Report

icon

#601

The World University Rankings

icon

#601

QS World University Rankings

Class Profile

Application Requirements

Here's everything you need to know to ensure a complete and competitive application—covering the key documents and criteria for a successful submission.

    • intake

      Cover Letter

    Application Deadlines

    Default
    springApr 2, 2026

    Ready to elevate your study abroad journey?

    Book a call with us now and take the first step towards your global future!

    Connect with us on our social media

    • icon
    • icon
    • icon
    • icon